Showing results (1211-1220 of 1,274) with videos related to
Sort By:
Pageof 128
The International Journal of Neuroscience|November 16, 2013
Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the regionAbdulrahman M Al Tahan, Isa Alsharoqi, Saeed A Bohlega, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2018
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trialsDorothea Buck, Till Fm Andlauer, Wilmar Igl, et al.British Journal of Haematology|June 13, 2009
Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphomaJonathan W Friedberg, Jennifer L Kelly, Donna Neuberg, et al.The Journal of Urology|April 1, 1996
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow upD A Tolley, M K Parmar, K M Grigor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervixA P Kudelka, T Levy, C F Verschraegen, et al.Neuro-Oncology|December 18, 2019
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II studyAndrew J Brenner, Katherine B Peters, James Vredenburgh, et al.The Lancet. Neurology|October 23, 2021
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trialAntonio Uccelli, Alice Laroni, Rehiana Ali, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With NicotinamideMitchell E Horwitz, Stephen Wease, Beth Blackwell, et al.The New England Journal of Medicine|June 1, 2017
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple SclerosisLuanne M Metz, David K B Li, Anthony L Traboulsee, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 23, 2008
Differential diagnosis of suspected multiple sclerosis: a consensus approachD H Miller, B G Weinshenker, M Filippi, et al.Pageof 128